The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Menzies-Gow, A.
Right arrow Articles by Kay, A. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Menzies-Gow, A.
Right arrow Articles by Kay, A. B.
The Journal of Immunology, 2002, 169: 2712-2718.
Copyright © 2002 by The American Association of Immunologists

Eotaxin (CCL11) and Eotaxin-2 (CCL24) Induce Recruitment of Eosinophils, Basophils, Neutrophils, and Macrophages As Well As Features of Early- and Late-Phase Allergic Reactions Following Cutaneous Injection in Human Atopic and Nonatopic Volunteers1

Andrew Menzies-Gow*, Sun Ying*, Ian Sabroe{dagger}, Victoria L. Stubbs{dagger}, Dulce Soler{ddagger}, Timothy J. Williams{dagger} and A. Barry Kay2,*

* Allergy and Clinical Immunology, National Heart and Lung Institute, and {dagger} Leukocyte Biology, Biomedical Sciences Division, Faculty of Medicine, Imperial College, London, United Kingdom; and {ddagger} Millennium Pharmaceuticals, Inc., Cambridge, MA 02139

Eotaxin and eotaxin-2, acting through CCR3, are potent eosinophil chemoattractants both in vitro and in animal models. In this study we examined the capacity of eotaxin and eotaxin-2 to recruit eosinophils and other inflammatory cells in vivo in human atopic and nonatopic skin. Skin biopsies taken after intradermal injection of eotaxin and eotaxin-2 were examined by immunohistochemistry. Allergen- and diluent-challenged sites were used as positive and negative controls. Eotaxin and eotaxin-2 produced a dose- and time-dependent local eosinophilia of comparable intensity in both atopic and nonatopic individuals. This was associated with an acute wheal and flare response at the site of injection and development of a cutaneous late phase reaction in a proportion of subjects. There was an accompanying decrease in mast cell numbers. Both chemokines also induced the accumulation of basophils and an unexpected early infiltration of neutrophils. Macrophages were prominent at the 24-h point. Although there was surface CCR3 expression on neutrophils in whole blood, we were unable to demonstrate any functional neutrophil responses to eotaxin in vitro. Thus, intradermal injection of eotaxin and eotaxin-2 in humans induced infiltration of eosinophils and other inflammatory cells as well as changes consistent with CC chemokine-induced mast cell degranulation.




This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
N. J. Stevenson, M. R. Addley, E. J. Ryan, C. R. Boyd, H. P. Carroll, V. Paunovic, C. A. Bursill, H. C. Miller, K. M. Channon, A. E. McClurg, et al.
CCL11 blocks IL-4 and GM-CSF signaling in hematopoietic cells and hinders dendritic cell differentiation via suppressor of cytokine signaling expression
J. Leukoc. Biol., February 1, 2009; 85(2): 289 - 297.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
N. Komatsu, D. Miyazaki, T. Tominaga, C.-H. Kuo, S. Namba, S. Takeda, H. Higashi, and Y. Inoue
Transcriptional Analyses before and after Suppression of Immediate Hypersensitivity Reactions by CCR3 Blockade in Eyes with Experimental Allergic Conjunctivitis
Invest. Ophthalmol. Vis. Sci., December 1, 2008; 49(12): 5307 - 5313.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
K. J. Haley, M. E. Sunday, Y. Porrata, C. Kelley, A. Twomey, A. Shahsafaei, B. Galper, L. A. Sonna, and C. M. Lilly
Ontogeny of the eotaxins in human lung
Am J Physiol Lung Cell Mol Physiol, February 1, 2008; 294(2): L214 - L224.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
E. J. Cheadle, K. Riyad, D. Subar, D. G. Rothwell, G. Ashton, H. Batha, D. J. Sherlock, R. E. Hawkins, and D. E. Gilham
Eotaxin-2 and Colorectal Cancer: A Potential Target for Immune Therapy
Clin. Cancer Res., October 1, 2007; 13(19): 5719 - 5728.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Farahi, A. S. Cowburn, P. D. Upton, J. Deighton, A. Sobolewski, E. Gherardi, N. W. Morrell, and E. R. Chilvers
Eotaxin-1/CC Chemokine Ligand 11: A Novel Eosinophil Survival Factor Secreted by Human Pulmonary Artery Endothelial Cells
J. Immunol., July 15, 2007; 179(2): 1264 - 1273.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. I. Ochkur, E. A. Jacobsen, C. A. Protheroe, T. L. Biechele, R. S. Pero, M. P. McGarry, H. Wang, K. R. O'Neill, D. C. Colbert, T. V. Colby, et al.
Coexpression of IL-5 and Eotaxin-2 in Mice Creates an Eosinophil-Dependent Model of Respiratory Inflammation with Characteristics of Severe Asthma
J. Immunol., June 15, 2007; 178(12): 7879 - 7889.
[Abstract] [Full Text] [PDF]


Home page
JDRHome page
T.A. Silva, G.P. Garlet, S.Y. Fukada, J.S. Silva, and F.Q. Cunha
Chemokines in Oral Inflammatory Diseases: Apical Periodontitis and Periodontal Disease
Journal of Dental Research, April 1, 2007; 86(4): 306 - 319.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Main, R. Handy, J. Wilton, S. Smith, L. Williams, L. D. Fou, J. Andrews, L. A. Conroy, R. May, I. Anderson, et al.
A Potent Human Anti-Eotaxin1 Antibody, CAT-213: Isolation by Phage Display and in Vitro and in Vivo Efficacy
J. Pharmacol. Exp. Ther., December 1, 2006; 319(3): 1395 - 1404.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
V. Chan, J. K. Burgess, J. C. Ratoff, B. J. O'Connor, A. Greenough, T. H. Lee, and S. J. Hirst
Extracellular Matrix Regulates Enhanced Eotaxin Expression in Asthmatic Airway Smooth Muscle Cells
Am. J. Respir. Crit. Care Med., August 15, 2006; 174(4): 379 - 385.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
V. E. Prescott, E. Forbes, Paul. S. Foster, Klaus. Matthaei, and S. P. Hogan
Mechanistic analysis of experimental food allergen-induced cutaneous reactions.
J. Leukoc. Biol., August 1, 2006; 80(2): 258 - 266.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
F. Huaux, M. Gharaee-Kermani, T. Liu, V. Morel, B. McGarry, M. Ullenbruch, S. L. Kunkel, J. Wang, Z. Xing, and S. H. Phan
Role of Eotaxin-1 (CCL11) and CC Chemokine Receptor 3 (CCR3) in Bleomycin-Induced Lung Injury and Fibrosis
Am. J. Pathol., December 1, 2005; 167(6): 1485 - 1496.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
B. O. Abonyo, M. S. Alexander, and A. S. Heiman
Autoregulation of CCL26 synthesis and secretion in A549 cells: a possible mechanism by which alveolar epithelial cells modulate airway inflammation
Am J Physiol Lung Cell Mol Physiol, September 1, 2005; 289(3): L478 - L488.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. de Paulis, N. Montuori, N. Prevete, I. Fiorentino, F. W. Rossi, V. Visconte, G. Rossi, G. Marone, and P. Ragno
Urokinase Induces Basophil Chemotaxis through a Urokinase Receptor Epitope That Is an Endogenous Ligand for Formyl Peptide Receptor-Like 1 and -Like 2
J. Immunol., November 1, 2004; 173(9): 5739 - 5748.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. Samoszuk, T. Deng, M. J. Hamamura, M.-Y. Su, N. Asbrock, and O. Nalcioglu
Increased Blood Clotting, Microvascular Density, and Inflammation in Eotaxin-Secreting Tumors Implanted into Mice
Am. J. Pathol., August 1, 2004; 165(2): 449 - 456.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
D Bumbacea, J Scheerens, B S Mann, R G Stirling, and K F Chung
Failure of sputum eosinophilia after eotaxin inhalation in asthma
Thorax, May 1, 2004; 59(5): 372 - 375.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. Jaruga, F. Hong, R. Sun, S. Radaeva, and B. Gao
Crucial Role of IL-4/STAT6 in T Cell-Mediated Hepatitis: Up-Regulating Eotaxins and IL-5 and Recruiting Leukocytes
J. Immunol., September 15, 2003; 171(6): 3233 - 3244.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. M. Phillips, V. E. L. Stubbs, M. R. Henson, T. J. Williams, J. E. Pease, and I. Sabroe
Variations in Eosinophil Chemokine Responses: An Investigation of CCR1 and CCR3 Function, Expression in Atopy, and Identification of a Functional CCR1 Promoter
J. Immunol., June 15, 2003; 170(12): 6190 - 6201.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
P. Forsythe and A. D. Befus
CCR3: A Key to Mast Cell Phenotypic and Functional Diversity?
Am. J. Respir. Cell Mol. Biol., April 1, 2003; 28(4): 405 - 409.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.